Telisotuzumab
Product Specifications
CAS Number
1781223-80-0
Target
C-Met/HGFR, Apoptosis
Related Pathways
Tyrosine Kinase/Adaptors, Apoptosis
Purity
0.985
Bioactivity
Telisotuzumab (ABT-700) is a humanized recombinant antibody targeting the therapeutic hepatocyte growth factor receptor (MET) with high affinity for c-Met.Telisotuzumab has inhibitory effects on c-Met signaling and antitumor activity.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
